BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26786600)

  • 21. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers.
    Tas C; Ozkan Y; Okyar A; Savaser A
    Drug Deliv; 2007 Oct; 14(7):453-9. PubMed ID: 17994363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of Azone and capsaicin on the permeation of naproxen through human skin.
    Degim IT; Uslu A; Hadgraft J; Atay T; Akay C; Cevheroglu S
    Int J Pharm; 1999 Mar; 179(1):21-5. PubMed ID: 10053198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of glycofurol-based gel as a new vehicle for topical application of naproxen.
    Barakat NS
    AAPS PharmSciTech; 2010 Sep; 11(3):1138-46. PubMed ID: 20652458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining.
    Lau WM; White AW; Heard CM
    Pharm Res; 2010 Dec; 27(12):2734-42. PubMed ID: 20872052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.
    Luo L; Patel A; Sinko B; Bell M; Wibawa J; Hadgraft J; Lane ME
    Int J Pharm; 2016 May; 505(1-2):14-9. PubMed ID: 27025294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.
    Shakeel F; Ramadan W; Ahmed MA
    J Drug Target; 2009 Jul; 17(6):435-41. PubMed ID: 19527114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organogels: "GelVolution" in Topical Drug Delivery - Present and Beyond.
    Nikam AN; Roy A; Raychaudhuri R; Navti PD; Soman S; Kulkarni S; Shirur KS; Pandey A; Mutalik S
    Curr Pharm Des; 2024; 30(7):489-518. PubMed ID: 38757691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-Dependent Behavior of Novel Gellan Beads Loaded with Naproxen.
    Osmalek T; Froelich A; Milanowski B; Bialas M; Hyla K; Szybowicz M
    Curr Drug Deliv; 2018; 15(1):52-63. PubMed ID: 28260506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of transdermal organogels containing nicorandil.
    Madan JR; Sagar B; Chellappan DK; Dua K
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):246-52. PubMed ID: 23746225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and local tissue disposition studies of naproxen-following topical and systemic administration in dogs and rats.
    Suh H; Jun HW; Dzimianski MT; Lu GW
    Biopharm Drug Dispos; 1997 Oct; 18(7):623-33. PubMed ID: 9330782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of penetration enhancers on in vitro percutaneous penetration of nimesulide through rat skin.
    Güngör S; Bergişadi N
    Pharmazie; 2004 Jan; 59(1):39-41. PubMed ID: 14964420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug.
    Valenta C; Wanka M; Heidlas J
    J Control Release; 2000 Jan; 63(1-2):165-73. PubMed ID: 10640590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
    Singh SK; Durrani MJ; Reddy IK; Khan MA
    Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
    Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
    Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical gels of lidocaine HCl using cashew gum and Carbopol 940: preparation and in vitro skin permeation.
    Das B; Nayak AK; Nanda U
    Int J Biol Macromol; 2013 Nov; 62():514-7. PubMed ID: 24099938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimisation of cosolvent concentration for topical drug delivery III--influence of lipophilic vehicles on ibuprofen permeation.
    Watkinson RM; Guy RH; Oliveira G; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2011; 24(1):22-6. PubMed ID: 20616625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.